Literature DB >> 19350003

Choosing between GVHD and delayed engraftment.

Paul J Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19350003     DOI： 10.1038/nm0409-363

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis.

Authors:  V T Ho; N Q Mirza; D del Junco Dd; T Okamura; D Przepiorka
Journal:  Bone Marrow Transplant       Date:  2003-10       Impact factor: 5.483

Review 2.  Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?

Authors:  Satkiran S Grewal; Juliet N Barker; Stella M Davies; John E Wagner
Journal:  Blood       Date:  2003-01-09       Impact factor: 22.113

3.  Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation.

Authors:  Allison Dekker; Sean Bulley; Joseph Beyene; L Lee Dupuis; John J Doyle; Lillian Sung
Journal:  J Clin Oncol       Date:  2006-11-20       Impact factor: 44.544

4.  Mortality hazard functions as related to neutropenia at different times after marrow transplantation.

Authors:  F Offner; G Schoch; L D Fisher; B Torok-Storb; P J Martin
Journal:  Blood       Date:  1996-11-15       Impact factor: 22.113

5.  Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

Authors:  V Rocha; J E Wagner; K A Sobocinski; J P Klein; M J Zhang; M M Horowitz; E Gluckman
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

6.  Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.

Authors:  Hanna J Khoury; Fausto R Loberiza; Olle Ringdén; A John Barrett; Brian J Bolwell; Jean-Yves Cahn; Richard E Champlin; Robert Peter Gale; Gregory A Hale; Alvaro Urbano-Ispizua; Rodrigo Martino; Philip L McCarthy; Pierre Tiberghien; Leo F Verdonck; Mary M Horowitz
Journal:  Blood       Date:  2005-10-20       Impact factor: 22.113

7.  A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation.

Authors:  H Hägglund; O Ringdén; S Oman; M Remberger; S Carlens; J Mattsson
Journal:  Bone Marrow Transplant       Date:  1999-10       Impact factor: 5.483

8.  Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.

Authors:  Eliane Gluckman; Vanderson Rocha; William Arcese; Gérard Michel; Guillermo Sanz; Ka-Wah Chan; Tsuneo A Takahashi; Juan Ortega; Alexandra Filipovich; Franco Locatelli; Shigetaka Asano; Franca Fagioli; Marcus Vowels; Anne Sirvent; Jean-Philippe Laporte; Karin Tiedemann; Sergio Amadori; Manuel Abecassis; Pierre Bordigoni; Blanca Diez; Peter J Shaw; Ajay Vora; Maurizio Caniglia; Federico Garnier; Irina Ionescu; Joan Garcia; Gesine Koegler; Paolo Rebulla; Sylvie Chevret
Journal:  Exp Hematol       Date:  2004-04       Impact factor: 3.084

9.  Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Olle Ringdén; Myriam Labopin; Norbert-Claude Gorin; Katarina Le Blanc; Vanderson Rocha; Eliane Gluckman; Jules Reiffers; William Arcese; Jaak M Vossen; Jean-Pierre Jouet; Catherine Cordonnier; Francesco Frassoni
Journal:  J Clin Oncol       Date:  2003-12-22       Impact factor: 44.544

10.  Induction of natural killer T cell-dependent alloreactivity by administration of granulocyte colony-stimulating factor after bone marrow transplantation.

Authors:  Edward S Morris; Kelli P A MacDonald; Rachel D Kuns; Helen M Morris; Tatjana Banovic; Alistair L J Don; Vanessa Rowe; Yana A Wilson; Neil C Raffelt; Christian R Engwerda; Angela C Burman; Kate A Markey; Dale I Godfrey; Mark J Smyth; Geoffrey R Hill
Journal:  Nat Med       Date:  2009-03-29       Impact factor: 53.440
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.